z-logo
open-access-imgOpen Access
Effectiveness and Cost-effectiveness of Immediate Versus Delayed Treatment of Hepatitis C Virus–Infected Patients in a Country With Limited Resources: The Case of Egypt
Author(s) -
Dorothée Obach,
Sylvie DeufficBurban,
Gamal Esmat,
Wagida A. Anwar,
Sahar Dewedar,
V. Canva,
Anthony Cousien,
Wahid Doss,
Aya Mostafa,
Stanislas Pol,
Marı́a Buti,
Uwe Siebert,
Arnaud Fontanet,
Mostafa K. Mohamed,
Yazdan Yazdanpanah
Publication year - 2014
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciu066
Subject(s) - medicine , virology , hepatitis c virus , virus , hepatitis a virus , cost effectiveness , intensive care medicine , immunology , risk analysis (engineering)
Because of logistical and economic issues, in Egypt, as in other resource-limited settings, decision makers should determine for which patients hepatitis C virus (HCV) treatment should be prioritized. We assessed the effectiveness and cost-effectiveness of different treatment initiation strategies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom